Equity Details
Price & Market Data
Price: $5.75
Daily Change: -$0.05 / 0.87%
Daily Range: $5.70 - $5.85
Market Cap: $1,193,975,552
Daily Volume: 85,967
Performance Metrics
1 Week: 6.09%
1 Month: 14.77%
3 Months: -8.59%
6 Months: 43.39%
1 Year: 63.82%
YTD: 23.66%
About Inventiva S.A. (IVA)
A concise financial summary for Inventiva S.A. (IVA). Priced at 5.75, it shows a daily movement of -$0.05 / 0.87%. Market cap: 1,193,975,552. Performance over 1-week and 1-year are key takeaways.
Company Details
Employees: 77
Sector: Health technology
Industry: Biotechnology
Country: France
Details
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.